Access 2.8M+ Filings Sign Up Free
Haemato AG Logo

Haemato AG | HAEK - Profile, Filings, Stock Info & Investor Relations Data

Haemato AG | HAEK
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Germany
Founded
1993
Haemato AG (HAEK)

Company Profile

Website
Investor Relations

About Haemato AG

HAEMATO has been committed for over 15 years as a pharmaceutical manufacturer and wholesaler to actively contributing to cost reduction in the healthcare sector, so that every patient can benefit from the latest therapies and treatment concepts, even if these are often very expensive. In addition, the Group focuses on the development and distribution of own brands in the Lifestyle & Aesthetics segment.

HAEMATO covers chronic diseases and high-priced therapies in particular with its own product portfolio. The focus is on the five therapeutic areas of HIV/AIDS, neurology, oncology, rheumatology and ophthalmology. These therapeutic areas include innovative, patent-protected drugs as well as biosimilars and generics. The product portfolio is rounded off with narcotics, which also include cannabis products.

Market Presence

Worldwide

Headquarters

Lilienthalstraße 3a
12529, Schönefeld
Germany

Haemato AG (HAEK)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Haemato AG (HAEK)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Haemato AG (HAEK)
Stock & Investor Information

ISINs

DE000A289VV1

LEI

529900Q3CGRYVCW7E340

Stock Exchange Listings

Frankfurt Stock Exchange

Primary Stock Exchange Listing

View Haemato AG on main exchange

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals